Pregnancy changes treatment planning, not the right to care
Substance use should be discussed with an obstetric and addiction clinician as early as possible without waiting for a crisis. The assessment needs the substance, amount, timing, route, withdrawal, medications, mental health, medical conditions, and prenatal status. Shame and punishment can discourage accurate disclosure. A qualified team can explain risks and options while treating the pregnant patient as the primary decision-maker in care; respectful assessment should address the substance, gestational age, health, mental health, medications, housing, safety, and treatment preferences.
Do not stop opioids or sedatives abruptly on your own
Rapid opioid withdrawal during pregnancy can create serious risks, and benzodiazepine or heavy alcohol withdrawal can also be medically dangerous. Contact a clinician before changing a regularly used substance or prescribed medicine. Emergency symptoms such as a seizure, severe confusion, bleeding, chest pain, suicidal behavior, or trouble breathing require immediate care. Online taper schedules cannot account for pregnancy, dose, co-use, or medical history; urgent evaluation is especially important when withdrawal, overdose, bleeding, severe pain, reduced fetal movement, or psychiatric danger is possible.
Methadone and buprenorphine are recommended for opioid use disorder
CDC and ACOG identify methadone and buprenorphine as recommended treatments for opioid use disorder during pregnancy. Medication should be coordinated with prenatal and addiction care rather than withheld because the patient is pregnant. Dose needs may change during pregnancy and after delivery, so clinical monitoring matters. Concern about newborn withdrawal alone should not drive a patient away from evidence-based maternal treatment; dosing and follow-up may change during pregnancy, so continuing care with experienced prescribers and obstetric clinicians is essential.
Care needs obstetric, addiction, and pediatric coordination
The treatment program should know who provides prenatal care, where delivery is planned, and how medication continues during hospitalization. Pediatric clinicians need information required to monitor and support the newborn. Ask how consent and substance-use confidentiality rules affect communication. A handoff should include current doses, other medicines, emergency contacts, transportation, and a plan for the first postpartum appointments; the team should agree on medication records, delivery communication, newborn observation, pain control, feeding questions, and follow-up responsibility.
Compare programs on practical access as well as medicine
Ask whether the program accepts pregnant patients at the current stage, offers or coordinates medication, and can manage co-occurring mental health and medical needs. Review transportation, childcare, housing, nutrition, intimate partner violence, and insurance barriers. Priority access rules and services vary by jurisdiction and funding source, so verify availability directly. Avoid facilities that demand abrupt discontinuation or promise a risk-free detoxification; transportation, childcare, insurance, housing, stigma, and fear of legal consequences can determine whether recommended care is practically reachable.
Overdose prevention remains necessary
Pregnancy does not protect against overdose, and an unpredictable drug supply can add opioid exposure the patient did not intend. Keep naloxone available when opioids may be involved and teach close contacts to call 911. Emergency care should not be delayed because of fear about disclosure or judgment. The team should also address alcohol, stimulants, tobacco, sedatives, and other substances rather than focusing only on the pregnancy; naloxone access and emergency response planning protect both pregnant patient and fetus when opioid exposure remains possible.
Postpartum support should be planned before delivery
Sleep loss, pain, mood changes, infant care, custody stress, and changes in treatment access can increase vulnerability after birth. Continue medication as prescribed and arrange addiction, obstetric, primary care, pediatric, and mental health follow-up. Discuss feeding and newborn care with qualified clinicians based on the complete situation. The written plan should name supportive people, transportation, safe medication storage, naloxone, and the response to missed doses or renewed use; sleep loss, mood symptoms, pain, medication changes, infant care, and reduced support can alter risk after birth.